Start a New Search
SHOWING 197 RESULTS
We strongly believe that financial transparency of federal award funds is essential to insuring public trust.
Reducing Regulatory Burden | Research Administration & Regulation | LettersYour new bill focuses on improving data standards and reporting, as well as streamlining financial reporting.
Reducing Regulatory Burden | Research Administration & Regulation | LettersThe nation's top research universities and AAMC issued a set of shared guidelines intended to protect the public interest when universities grant licenses for the rights to their latest scientific advances to private parties.
Intellectual Property | Technology Transfer | Research Administration & Regulation | Stanford University | Press ReleasesThose concerns have centered on the imposition of redundant and costly reporting requirements. The revised bill would eliminate explicitly duplicative reporting within three years.
Research Administration & Regulation | Reducing Regulatory Burden | LettersThe Heart of the Matter, a report of the American Academy’s Commission on the Humanities and Social Sciences, is intended to advance a dialogue on the importance of the humanities and social sciences to the future of our nation.
Humanities | Reportsstatement by Hunter Rawlings, President of the Association of American Universities (AAU), on the deep cut proposed for the National Endowment for the Humanities in the FY15 appropriations bill approved July 9 by the House Appropriations Subcommittee on Interior, Environment, and Related Agencies.
Humanities | National Endowment for the Humanities | Federal Budget | StatementsAAU, APLU, COGR letter on proposed changes to NIH guidelines for human stem cell research and consideration of certain human-animal chimera research.
Research Administration & Regulation | National Institutes of Health | LettersRe: Retrospective Review: Identifying and Reducing Regulatory Burdens; 81 FR 4213
Research Administration & Regulation | Reducing Regulatory Burden | LettersIn the US, ketamine is currently a Schedule III drug under the Controlled Substances Act, and strict regulations and safeguards are already in place to prevent its illegal use.
Research Administration & Regulation | Reducing Regulatory Burden | Higher Education Regulation | LettersRe: "Petition to Develop Specific Ethologically Appropriate Standards for Nonhuman Primates in Research"
Research Administration & Regulation | Letters